OnlyLuck
赞了
周一早上开盘我最看好的是 $Aerpio Pharmaceuticals (ARPO.US)$ 生物制药的尽心研究非常关键....第二阶段糖尿病视网膜病变,第10亿阶段肠易激综合症等
我第二选择是 $Artelo Biosciences (ARTL.US)$ 具有分析师预期涨幅174%。
我不是专业投资者,请进行尽职调查,这是必需的...
祝交易好运 🤣
$Ocugen (OCGN.US)$ $HUMBL INC ORD (TSNPD.US)$ 最喜欢的吸烟品牌 $Zomedica (ZOM.US)$大家都知道 $Workhorse (WKHS.US)$
我第二选择是 $Artelo Biosciences (ARTL.US)$ 具有分析师预期涨幅174%。
我不是专业投资者,请进行尽职调查,这是必需的...
祝交易好运 🤣
$Ocugen (OCGN.US)$ $HUMBL INC ORD (TSNPD.US)$ 最喜欢的吸烟品牌 $Zomedica (ZOM.US)$大家都知道 $Workhorse (WKHS.US)$
已翻译
13
OnlyLuck
赞了
$Artelo Biosciences (ARTL.US)$ 分析师7号和买入等在观察清单上,需要做更多的调研和筹钱买新的 🙂
已翻译
2
2
OnlyLuck
赞并评论了
2
5
OnlyLuck
评论了
$克莱瑞恩 (CLSN.US)$ AH可能会给我们提供一个回调买入的机会😉我还在尽力买入回调
已翻译
3
7
OnlyLuck
赞了
$zomedica公司(ZOm.US) 这是一个不错的公司,在三月底之前如果你操作得当,还有机会赚钱。买入低点,卖出高峰。10、15、20%的收益是不错的收益,也是建立投资组合的好方法,尤其对于那些经验不多、资金不多的人来说。如果你现在正处于这个阶段,不要害羞或尴尬,大多数刚开始自己交易的人应该从小规模开始,不要把整个银行、租金、车贷、食品消费等资金全部押上,你会亏掉的。学习一切,YouTube和书店上有大量的信息。从摇摆交易开始,也就是每2到14天进行一次交易,当股票跌时买入,然后持有直到股票回升后再卖出,只是为了练习。大多数人都认为,Zomedica公司将在三月底或者发布产品给公众时会有一个大涨,这是一家不错的公司。最后一点,不要用情绪来交易。你的感觉每次都是错误的,要用事实来操作,学习,学习,学习。
已翻译
12
7
OnlyLuck
赞并评论了
$Vaccinex (VCNX.US)$可能即将有公告发布。内部购买增长了231%。机构购买增长了20%。
已翻译
4
4
OnlyLuck
赞了
the analysts have cut their price target 43% to CA$0.40, suggesting concerns around Sundial Growers' valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Sundial Growers at CA$1.01 per share, while the most bearish prices it at CA$0.20.
Overall, given the drastic downgrade to next year's forecasts, we'd be feeling a little more wary of Sundial Growers going forwards.As you can see, the analysts clearly aren't bullish, and there might be good reason for that. We've identified some potential issues with Sundial Growers' financials, such as major dilution from new stock issuance in the past year.
...
Overall, given the drastic downgrade to next year's forecasts, we'd be feeling a little more wary of Sundial Growers going forwards.As you can see, the analysts clearly aren't bullish, and there might be good reason for that. We've identified some potential issues with Sundial Growers' financials, such as major dilution from new stock issuance in the past year.
...
3